Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Toxicologic Pathology|July 6, 2018
Bone Toolbox: Biomarkers, Imaging Tools, Biomechanics, and HistomorphometryAurore Varela, Jacquelin Jolette
Journal of Bone and Mineral Metabolism|March 18, 2014
The effects of bazedoxifene in the ovariectomized aged cynomolgus monkeySusan Y Smith, Jacquelin Jolette, Luc Chouinard, et al.
Neurosurgery|June 24, 2010
Thermal damage assessment of novel bipolar forceps in a sheep model of spinal surgeryEbonia W Elliott-Lewis, Jacquelin Jolette, Jandira Ramos, et al.
Toxicologic Pathology|November 10, 2020
Case Studies Discussing the Pathology, Immunogenicity, and Proposed Mechanism of Toxicity of an Inhaled Anti-TGFβ Humanized Fab Antibody in Non-Human Primates and MiceAnthony Peter Hall, Annick Cauvin, Sherri Dudal, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 6, 2014
Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeysPaul J Kostenuik, Susan Y Smith, Rana Samadfam, et al.
Bone|April 5, 2011
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibodyPaul J Kostenuik, Susan Y Smith, Jacquelin Jolette, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2013
The effect of rosiglitazone on bone mass and fragility is reversible and can be attenuated with alendronateSanjay Kumar, Sandra J Hoffman, Rana Samadfam, et al.
Regulatory Toxicology and Pharmacology : RTP|April 9, 2017
Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34)Jacquelin Jolette, Bassem Attalla, Aurore Varela, et al.
Toxicologic Pathology|December 21, 2006
Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 ratsJacquelin Jolette, Clynn E Wilker, Susan Y Smith, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2016
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus MonkeysMichael S Ominsky, Steven K Boyd, Aurore Varela, et al.
Pageof 2